3 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
inhibitors in CVD ... in HFrEF on GDMT ... outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
showed reduced risk ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... > 1% risk of CV ... CARP, DECREASE V trials ... medical and surgical management ... stratification #diagnosis